MEDS — DataMeds AI, Inc.
—
Nasdaq ·
Consumer Discretionary ·
Distributors ·
CIK 2030763 ·
Last close
$0.64
Market Cap
$3.32M
52W High
$33.15
52W Low
$0.49
ADV30
1,911,359
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 2,668,980 | 431,880 | -3,373,956 | 10,589,764 | 38,733,868 | 476,598 | 38,562,173 |
| Jun 2026 | 1,779,860 | 182,204 | -7,345,054 | -18,363,225 | 32,759,432 | 2,456,373 | 52,263,663 |
| Mar 2026 | 1,559,563 | 170,221 | -6,015,538 | -7,742,597 | 30,127,690 | 51,730 | 45,190,139 |
| Dec 2025 | 1,670,648 | -7,855,824 | -12,797,758 | -27,852,959 | 30,459,449 | 42,571 | 42,907,250 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,735,909
Investing CF
$-923,697
Financing CF
$16,696,038
CapEx
$-923,697
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-39.03
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-137,137,512
Inventory
$1,510,123
Receivables
$1,200,404
ST Investments
—
EBIT TTM
$-82,342,040
Pretax Income TTM
$-88,276,985
Interest Exp TTM
$5,934,945
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,022,975
EBITDA
$-55,387,860
Free Cash Flow
$2,370,213
Enterprise Value
$32,443,636
Total Cash
$2,456,373
Total Debt
$32,622,248
Shares Out
5,182,529
Trailing EPS
$-46.68
Book Value
$-6.14
ROE
—
ROA
-82.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 23,337,860 | -81,194,831 | -101,274,530 | 30,459,449 | 42,907,250 | -12,447,801 | -10,855,029 |
| Dec 2024 | 18,128,831 | -6,145,132 | -6,856,226 | 57,332,650 | 50,598,204 | 6,734,446 | -1,224,993 |
| Dec 2023 | 0 | -2,880,603 | -2,895,684 | 338,364 | 3,238,798 | -2,900,434 | -349,136 |
| Dec 2022 | 32,777,728 | -3,422,729 | -2,743,800 | 0 | 5,250 | -5,250 | 0 |
TTM Snapshot
Revenues TTM
$8,022,975
NetIncome TTM
$-88,276,985
OpCashFlow TTM
—
Assets (Latest)
$32,759,432
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HYFM | HYDROFARM HOLDINGS GROUP, INC. | $3.28M | $0.68 | — |
| BANL | CBL International Ltd | $3.44M | $3.13 | — |
| BGMS | Bio Green Med Solution, Inc. | $3.91M | $0.59 | — |
| CGTL | Creative Global Technology Holdings Ltd | $2.81M | $2.44 | — |
| GDC | GD Culture Group Ltd | $4.37M | $1.05 | — |
News headlines (Yahoo Finance, 1h cache)
DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
2026-11-05 11:49 · Yahoo
DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee Recommendations
2026-11-02 11:42 · Yahoo
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
2026-10-23 10:45 · Yahoo
DataMeds Regains Compliance With NASDAQ Listing Standards
2026-10-20 10:00 · Yahoo
DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
2026-10-16 10:56 · Yahoo
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
2026-10-16 10:00 · Yahoo
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
2026-10-14 13:48 · Yahoo
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
2026-10-13 16:11 · Yahoo
DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
2026-10-13 11:02 · Yahoo
DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
2026-10-12 14:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.